RecruitingPhase 3NCT07029711
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- Ritlecitinib higher dose(drug)
- Enrollment
- 225 enrolled
- Eligibility
- 6-11 years · All sexes
- Timeline
- 2025 – 2027
Study locations (30)
- California Dermatology & Clinical Research Institute, Encinitas, California, United States
- University of California - Irvine, Irvine, California, United States
- Investigational Drug Service - Rady Children's Hospital-San Diego, San Diego, California, United States
- University of California, San Diego/Rady Children's Hospital-San Diego;, San Diego, California, United States
- Southern California Clinical Research, Santa Ana, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Pediatric Skin Research, Miami, Florida, United States
- D&H Tamarac Research Center, Tamarac, Florida, United States
- Endeavor Health Clinical Operations, Skokie, Illinois, United States
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
- Equity Medical - Bowling Green, Bowling Green, Kentucky, United States
- Kindred Hair and Skin Center, Marriottsville, Maryland, United States
- Michigan Dermatology Institute, Waterford, Michigan, United States
- University of Minnesota Health Clinical Research Unit (M Health CRU), Minneapolis, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07029711 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC